Serum levels of caffeine in umbilical cord and apnea of prematurity

Jornal de Pediatria

Volumn 86, Issue 2, 2010, Pages 137-142

  Hentges, Cláudia Regina ^a,b   Guedes, Renata Rostirola ^a,b   Silveira, Rita C ^a,b   Procianoy, Renato S ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Apnea; Caffeine; Low birth weight infant; Prematurity

Indexed keywords

CAFFEINE;

APNEA; ARTICLE; ASSISTED VENTILATION; CLINICAL TRIAL; CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; PERINATAL ASPHYXIA; PREMATURITY; UMBILICAL CORD; UMBILICAL CORD BLOOD;

EID: 77951518807     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1990     Document Type: Article

References (26)

1. Henderson-Smart DJ, Steer P. Methylxanthine treatment for apnea in preterm infants. Cochrane Database Syst Rev. 2001: CD000140.
2. Aranda JV, Gorman W, Bergsteinsson H, Gunn T. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr. 1977;90:467-472 (Pubitemid 8052244)
3. Janvier A, Khairy M, Kokkotis A, Cormier C, Messmer D, Barrington KJ. Apnea is associated with neurodevelopmental impairment in very low birth weight infants. J Perinatol. 2004;24:763-768 (Pubitemid 39618583)
4. de Souza RA, Schieri R.Caffeine intake and prematurity. Rev Nutr. 2005;18:643-650
5. Boylan SM, Cade JE, Kirk SF, Greenwood DC, White KL, Shires S, et al. Assessing caffeine exposure in pregnant women. Br J Nutr. 2008;100:875-882
6. Grosso LM, Triche E, Benowitz NL, Bracken MB. Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake? Ann Epidemiol. 2008;18:172-178
7. Chamberlain G. ABC of antenatal care. Checking for fetal wellbeing - I. BMJ. 1991;302:837-839
8. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol. 1996;87:163-168 (Pubitemid 26033124)
9. Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P; International Small for Gestational Age Advisory Board. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics. 2003;111:1253-1261
10. Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am. 2004;51:939-959, VIII-IX.
11. Silveira RC, Procianoy RS. Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis. Acta Paediatr. 1999;88:647-650
12. Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath P. Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed. 2005;90:F220-4.
13. Poblano A, Marquez A, Hernandez G. Apnea in infants. Indian J Pediatr. 2006;73:1085-1088
14. Schreiber-Deturmeny E, Bruguerolle B. Simultaneous high-performance liquid chromatographic determination of caffeine and theophylline for routine drug monitoring in human plasma. J Chromatogr B Biomed Appl. 1996;677:305-312 (Pubitemid 26105999)
15. Biaggioni I, Paul S, Robertson D. A simple liquid chromatographic method applied to determine caffeine in plasma and tissues. Clin Chem. 1988;34:2345-2348 (Pubitemid 19001271)
16. Pickard CE, Stewart AD, Hartley R, Lucock MD. A rapid HPLC method for monitoring plasma levels of caffeine and theophylline using solid phase extraction columns. Ann Clin Biochem. 1986;23:440-446 (Pubitemid 16095779)
17. Tanaka E. Simultaneous determination of caffeine and its primary demethylated metabolites in human plasma by high-performance liquid chromatography. J Chromatogr. 1992;575:311-314
18. Foenander T, Birkett DJ, Miners JO, Wing LM. The simultaneous determination of theophylline, theobromine and caffeine in plasma by high performance liquid chromatography. Clin Biochem. 1980;13:132-134 (Pubitemid 11163785)
19. Scott NR, Chakraborty J, Marks V. Determination of caffeine, theophylline and theobromine in serum and saliva using high performance liquid chromatography. Ann Clin Biochem. 1984;21:120-124 (Pubitemid 14121405)
20. McCulloch KM, Braun RJ, Simms PE, Evans MA, Kelly DH. Transplacentally acquired caffeine and the occurrence of apnea, bradycardia, and periodic breathing in preterm infants: preliminary communication. Pediatr Pulmonol. 1989;7:66-70.
21. Toubas PL, Duke JC, McCaffree MA, Mattice CD, Bendell D, Orr WC. Effects of maternal smoking and caffeine habits on infantile apnea: a retrospective study. Pediatrics. 1986;78:159-163
22. Bodineau L, Cayetanot F, Sådani-Makki F, Bach V, Gros F, Lebleu A, et al. Consequences of in utero exposure on respiratory output in normoxic and hypoxic conditions and related changes of Fos expression: a study on brainstem-spinal cord preparations isolated from newborn rats. Pediatr Res. 2003;53:266-273 (Pubitemid 36177123)
23. Herlenius E, Adén U, Tang LQ, Lagercrantz H. Perinatal respiratory control and its modulation by adenosine and caffeine in the rat. Pediatr Res. 2002;51:4-12. (Pubitemid 34008203)
24. McGowan JD, Altman RE, Kanto WP Jr. Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J. 1988;81:1092-1094
25. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354:2112-2121
26. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357:1893-1902 (Pubitemid 350074685)